Work

Sa1879 EFFICACY AND SAFETY OF VEDOLIZUMAB REINITIATION FOLLOWING TREATMENT INTERRUPTION: POST HOC ANALYSIS OF THE VISIBLE TRIAL DATA

Year: 2020

Type: conference-abstract

Source: Gastroenterology

DOI: 10.1016/s0016-5085(20)31838-2

Authors: William J. Sandborn, Silvio Danese, Johan P. Jansson, Jingjing Chen, Sharif M. Uddin, Ninfa Candela, Karen Lasch, Krisztina Kisfalvi

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3027824367

Cites:

Cited by: 1

Related to: 10